Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1936 to 1950 of 8234 results

  1. CAEL-101 with standard care for untreated amyloid light chain amyloidosis [ID6210]

    Awaiting development Reference number: GID-TA11182 Expected publication date: TBC

  2. Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]

    Topic prioritisation

  3. Natural Cycles for monitoring fertility

    Topic prioritisation

  4. Waldenstrom's macroglobulinaemia - ibrutinib [ID884]

    In development Reference number: GID-TA10046 Expected publication date:  22 November 2017

  5. Regorafenib for treating advanced gastrointestinal stromal tumours [ID1056]

    In development Reference number: GID-TA10089 Expected publication date:  15 November 2017

  6. NY-ESO-1 T-cells for treating synovial sarcoma ID1286

    In development Reference number: GID-TA10205 Expected publication date: TBC

  7. Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests

    In development Reference number: GID-DG10038 Expected publication date: TBC

  8. Bladder EpiCheck for the detection of bladder cancer recurrence (MT706)

    Topic prioritisation

  9. Lumella Pre-Eclampsia Test (MT687)

    Topic prioritisation

  10. OTL-101 for treating adenosine deaminase deficiency–severe combined immunodeficiency [ID1152]

    Awaiting development Reference number: GID-HST10022 Expected publication date: TBC

  11. Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

    Topic prioritisation

  12. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

  13. eXroid for internal haemorrhoids

    Topic prioritisation

  14. Respirasense

    Topic prioritisation

  15. Cyanoacrylate glue for hernia mesh fixation

    Topic prioritisation